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Abstract
Acute pancreatitis is an acute clinical condition where it can be manifested as 
mild disease or serious and life-threatening condition. There are several factors that 
may be responsible for this condition, such as genetic, gallstone disease, alcohol 
consumption, pancreatic trauma, medication, hypertriglyceridemia, autoimmune 
disease, and surgery. The most common manifestation of pancreatic parenchymal 
injury is pancreatic pseudocyst (PPC) formation, where peripancreatic fluid collec-
tion (PFCs) usually precedes this condition. Even though most of the pseudocyst 
can be managed conservatively, however in conditions such as infected pseudocyst 
or possible wall of necrosis (WON), there should be an early intervention manage-
ment. Clinical evaluation and imaging studies have to be done in the beginning. 
Computed tomography (CT) scan or magnetic resonance imaging (MRI) are the 
main imaging techniques used to evaluate the characteristic of the cyst, the size, 
surrounding vascularity, and to assess the pancreatic duct itself with possible of 
fistula formation. Clinical conditions that are usually considered for early interven-
tion management are symptomatic pseudocyst, large size of pseudocyst, presence 
of gastric outlet obstruction, or biliary obstruction. PFC should be evaluated as it 
has been classified based on type of pancreatitis, time frame, well-defined wall, and 
debris contained inside the cyst. Endoscopic management has replaced percutane-
ous and surgical approach in most of PFC cases. Nowadays, endoscopic ultrasound 
(EUS) has been widely used as the first-line tool for PFC drainage procedure. 
Pancreatic pseudocyst stenting is the most common procedure in most of the 
centers in the world. However, the cost, availability, and expertise are needed to be 
considered in clinical practice.
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1. Introduction
Acute pancreatitis is one of the challenging situations in clinical practice where 
it can lead to a critical condition. This condition also needs to be carefully managed 
to prevent more complications [1]. One of the major complications is acute peripan-
creatic fluid collections (APPFC) and pseudocyst development [2, 3]. The clinical 
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decision for pancreatic pseudocyst or necrotic infected cyst drainage procedure is 
very important with regard to the patient’s clinical condition and imaging evalua-
tion. There are several well-known routes of drainage procedure of choice such as 
percutaneous, endoscopic, or surgical drainage [4].
Recently, development of therapeutic endoscopic ultrasound (EUS) procedure 
has become more popular in most of the highly experienced centers as a first-line 
management in pancreatic fluid collection drainage [5–7] (Figure 1). However, it 
would need a good comprehensive team work and facilities to perform this kind of 
procedure.
2. Acute pancreatitis and pancreatic fluid collection
Acute pancreatitis is an acute clinical condition due to sudden inflammation of 
the pancreas, and it is mostly caused by gallstone disease or alcohol consumption. 
The other risks of acute pancreatitis are endoscopic retrograde cholangiopan-
creatography (ERCP) procedure, some medications, trauma of the abdomen, 
autoimmune disease, hypertriglyceridemia, hereditary factors, abnormalities of 
the pancreas anatomy, infection, surgical procedure, and pancreatic tumor. Acute 
pancreatitis consists of two phases of disease: (1) within 1 week, where the systemic 
inflammation plays an important role and it can be accompanied by organ failure; 
and (2) more than 1 week, where local complications happened, such as acute 
peripancreatic fluid collections (APPFC), acute necrotic fluid collection (ANC), 
pancreatic pseudocyst (PPC), and walled-off necrosis (WON), either can be sterile 
or infected. This has been classified based on the revised Atlanta criteria. This 
criteria has been mainly based on time after the onset (whether it is ≤4 weeks or 
>4 weeks from the onset of pain) and whether there is a necrosis condition through 
the imaging examination [7, 8]. Acute pancreatitis can be easily diagnosed based 
on three classic parameters, which are abdominal pain, serum amylase, and/or 
lipase more than three times upper limit normal, and abdominal imaging study. 
Abdominal ultrasound should be routinely performed in acute pancreatitis patients 
as gallstone disease is still the most common etiology. This issue is important to 
consider early cholecystectomy to prevent more complications in the pancreas [9].
On the other hand, the development of PFC can also be subdivided into early 
complication (APPFC and ANC) and delayed complication (PPC and WON). 
APPFC, which contains sterile pancreatic juice, is usually developed within 48 h 
in almost 50% acute pancreatitis patients, where this condition might be resolved 
within 2–4 weeks. In the imaging study, homogeneous fluid attenuation con-
forms to the retroperitoneal structures without any wall which is the hallmark. 
Figure 1. 
Patient with infected pancreatic pseudocyst and acute pancreatitis [6].
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Meanwhile, ANC can be located pancreatic, peripancreatic, or mixed. It is usually 
arising from the necrotic pancreas tissue or glandular and mostly it is connected to 
the pancreatic duct. Imaging study showed inhomogeneous without any liquefied 
components and wall. If the fluid collection persists, then usually it can further lead 
to the development of PPC. PPC is a pancreatic juice collection surrounded by the 
wall. The location of pseudocyst development usually is at the lesser sac. The cyst 
wall is formed from the fibrous or granulomatous tissue. Based on imaging stud-
ies, it is an oval-round cystic lesion with a thin-walled even though sometimes the 
wall can be thicker. More than 50% of PPC are usually either resolved or drained 
spontaneously into the stomach. The larger size of PPC can cause symptoms such as 
abdominal pain or rupture into the peritoneal cavity. Other related complications 
are secondary infection, internal bleeding, and bile duct or duodenal obstruc-
tion. WON is the transformation of pseudocyst and ANC; it is a thick cavity wall 
containing semi-liquid collection and necrotic debris. Based on the imaging study, 
there is an inhomogeneous nonliquefied component encapsulated with wall. 
Imaging studies are very important to differentiate each of PFC types, as it will have 
different management and prognosis [10, 11].
3.  Endoscopic management of pancreatic fluid collection: history and 
development
Traditionally, percutaneous and surgical approaches are the old standard 
methods for PFC (PPC and WON) drainage, where the percutaneous approach can 
be performed easily for PPC drainage with transabdominal ultrasound-guided or 
computed tomography (CT) guide. Meanwhile, the surgical approach is the usually 
preferred method, especially for ANC or WON. It is an open approach and consists 
of cystogastrostomy, cystoduodenostomy, and cystojejunostomy. Laparoscopic 
method for PFC drainage was also increasingly reported afterward. However, 
looking at the high complication rate of surgery approach and possible ineffec-
tive drainage result with high recurrence rate in percutaneous approach, recently, 
endoscopic method has become a new alternative route and the most preference 
method nowadays [12].
The first report was published by Sahel et al. in 19 patients with chronic pancre-
atitis [13]. The complications occurred in four patients (bleeding in two patients, 
and two perforations). Another pioneer study by Cremer et al. also showed high 
success rate for endoscopic cystoduodenostomy (ECD) and 100% for endoscopic 
cystogastrostomy (ECG) [14]. However, both studies were performed in small 
sample size. Study by Weckman et al. in larger study subjects within 6 years 
period showed 86.1% success rate for endoscopic management in PPC patients 
with around 13.9% needing surgical intervention due to unsuccessful therapeutic 
endoscopy [15].
More studies have been conducted regarding endoscopic transpapillary stenting 
for pancreatic duct (PD) leak or disruption causing PPC or fistula, and also endo-
scopic management in WON. First, study by Catalano et al. performing endoscopic 
cystenterostomy in 8 of 21 PPC patients with duct strictures was successful in all 
cases [16]. In the recent study of transpapillary management route by Brennan 
et al., where it only included 30 patients with the indications of PD stenting were 
PPC, pancreatic ascites, pancreatic duct leak, and fistula, the follow-up success rate 
after PD stenting for pancreatic duct rupture was 88%, while for pseudocyst, it was 
63% [17]. In the WON study, endoscopic treatment was performed in 101 patients. 
The therapeutic success rate was 98.02%; whereas, long-term follow-up success rate 
was 96.04% in patients with symptomatic WON [18].
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The clinical decision when to intervene the PFC is usually based on comprehen-
sive clinical and imaging evaluation. Gastric outlet obstruction or biliary obstruc-
tion needs to be managed as soon as possible (Figure 2). It can be recognized early 
through the clinical symptoms such as abdominal pain, vomiting, weight loss, early 
satiety, or even jaundice. Infected PPC is one of the absolute indications for drain-
age procedure (Figure 3). Imaging evaluation as well as the fluoroscopy-guided 
or transabdominal-guided endoscopic management is considered as an important 
thing, especially in non-bulging PPC [19].
Nowadays, endoscopic ultrasound (EUS) has replaced the traditional way to 
do the drainage procedure. Through EUS examination, it is easy to evaluate non-
bulging PFC as well as other factors, such as the puncture site with large vessels 
avoidance, accurate fluid aspiration with the wall evaluation, and pancreatic duct 
connection. Defining the characteristics of each PFC type can also be easily done 
through EUS examination as the location and the size of the PFC, including the 
solid material, the wall, and the border, can be scored. It can also evaluate the bile 
duct under direct visualization [20].
The indication for endoscopic management is usually based on the patient’s 
symptoms, the resolution or severity of infections, and the size of the cyst. Another 
consideration involves the cyst wall maturity. Usually, the right time to perform 
endoscopic intervention is after 4 weeks as it allowed better encapsulation. Recent 
systematic review, comparing percutaneous, surgical, and endoscopic methods in 
managing PPC, shows that endoscopic management using EUS reduced the length 
of hospital admission time, cost, and improved patient’s quality of life [21, 22].
Figure 3. 
Patient with infected pancreatic pseudocyst and biliary obstruction (Courtesy: Dr. Cosmas Rinaldi 
A. Lesmana).
Figure 2. 
Patient with pancreatic pseudocyst and gastric outlet obstruction [6].
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4.  Endoscopic ultrasound-guided pancreatic fluid collection drainage: 
technical review
There are two options of endoscopic drainage method, which are transmural, 
transpapillary, or even combining these two techniques. In the pseudocyst case, 
endoscopic ultrasound (EUS) has been widely used for transmural drainage with 
previous evaluation where direct visualization of cystic lesions through the gastro-
intestinal (GI) lumen can be easily performed. It has become the most important 
tool in the management for pancreatic cyst, especially to differentiate benign 
from malignant condition. However, other than anatomic factor, the presence of 
ductal communication is also an important factor to decide which route is better 
to perform. In the WON case, the principle is the same; however, the fluid collec-
tion resolution after 72 h is the main consideration for more aggressive endoscopic 
intervention, which is known as EUS-guided transmural necrosectomy procedure. 
The drainage procedure can be done either with transpapillary or transmural 
approach. The needle puncture is performed using 19-G FNA needle. After the tip 
of the needle entering the cyst cavity, the needle sheath can be left inside by pulling 
out the needle and the guide wire was inserted through the needle sheath until it 
is coiled up. Then, the sheath was pulled out with maintaining the wire inside the 
cyst cavity. The dilatation process will further be performed either with dilator or 
5 or 6-fr cystotome to make a larger fistula. Finally, the stent is inserted through the 
fistula track (plastic or metallic stent) [23–26].
5. Endoscopic management: metal vs. plastic stent
There are two types of stents that are usually used in the management of PPC: 
metal stent and double pigtail plastic stent. There have been some concerns about 
using the plastic stents, which are possible for re-intervention due to ineffective 
drainage, longer procedure time regarding the need of two plastic stents place-
ment, or even the risk of leakage. However, some studies have shown that plastic 
stent success rate for PPC drainage ranges from 84 to 94%, but the success rate was 
found to be lower in few studies when managing WON cases [27–29]. One of the 
studies by Bang et al. showed that there was no difference for the treatment success 
between 7 and 10 Fr plastic stents, and even only one plastic stent placement when 
compared to more than one plastic stents. Another consideration need to be put in 
clinical practice is the cost, where it would be cheaper to use the plastic stent [30]. 
Recent meta-analysis study showed that there was a higher clinical success rate (OR 
3.39, 95% CI 1.35–21.19) and lower adverse events (OR 0.37, 95% CI 0.21–0.66) in 
the metal stent studies. The concern is regarding adverse events, such as bleeding, 
perforation, and stent migration. Fully covered metallic stent (FCMS) might be 
considered better in bleeding prevention due to the tamponade direct effect from 
the stent. In the subgroup analysis, even though the success rate in the metal stent 
group was 98.3%, however, the success rate in the plastic stent group also more 
than 90%. The success rate in the plastic group was below than 90% only in the 
WON group, where the metal stent group has still more than 90% success rate [31]. 
Another development in the stent evolution, lumen apposing metal stent (LAMS) 
development where this stent is used not only for endoscopic drainage procedure, 
but also for endoscopic necrosectomy procedure. This stent has also advantage in 
migration prevention when compared to FCMS [32–35].
Until now, there are still debates and conflicting data with regard to the use of 
type of the stents. However, even though technically there is no significant differ-
ence between placing metal stent versus plastic stent, every type of case need to 
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of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
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be decided individually as the cost issue, stent availability, PFC type, and possible 
complications are still important things for clinical consideration.
6. Conclusions
Acute pancreatitis with pancreatic fluid collection (PFC) is a challenging condi-
tion in the field of gastroenterology as it would need good comprehensive clinical 
assessment and good timing to decide when to intervene. Transmural approach 
through endoscopic procedure has replaced percutaneous or surgical approach to 
manage pancreatic pseudocyst. The use of metal stent seemed to be superior than 
the plastic stent for PFC drainage, however, it would be depending on the cost, 
availability, and the type of PFC.
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